APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Vaccine

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Selected research

Industry Research

BCG Vaccine Industry Research Report 2026

1 January 2026116 pages

Choose your research edition.

Industry ResearchBCG Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal BCG Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.

Report Scope

Read the full market overview

This report quantifies the global BCG Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

BCG Vaccine Market by Company

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

Serum Institute of India

Intervax

GSBPL

BCG Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Vaccine Segment by Application

Hospitals

Clinics

Others

BCG Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of BCG Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of BCG Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global BCG Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global BCG Vaccine Sales (MT) of Manufacturers (2021-2026) Table 7. Global BCG Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global BCG Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global BCG Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market BCG Vaccine Average Price (USD/Kg) of Manufacturers (2021-2026) Table 11. Global BCG Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of BCG Vaccine, Product Type & Application Table 14. Global BCG Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global BCG Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 21. Merck BCG Vaccine Product Portfolio Table 22. Merck Recent Developments Table 23. Sanofi Pasteur Company Information Table 24. Sanofi Pasteur Business Overview Table 25. Sanofi Pasteur BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 26. Sanofi Pasteur BCG Vaccine Product Portfolio Table 27. Sanofi Pasteur Recent Developments Table 28. Japan BCG Lab Company Information Table 29. Japan BCG Lab Business Overview Table 30. Japan BCG Lab BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 31. Japan BCG Lab BCG Vaccine Product Portfolio Table 32. Japan BCG Lab Recent Developments Table 33. China National Biotec Company Information Table 34. China National Biotec Business Overview Table 35. China National Biotec BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 36. China National Biotec BCG Vaccine Product Portfolio Table 37. China National Biotec Recent Developments Table 38. Serum Institute of India Company Information Table 39. Serum Institute of India Business Overview Table 40. Serum Institute of India BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 41. Serum Institute of India BCG Vaccine Product Portfolio Table 42. Serum Institute of India Recent Developments Table 43. Intervax Company Information Table 44. Intervax Business Overview Table 45. Intervax BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 46. Intervax BCG Vaccine Product Portfolio Table 47. Intervax Recent Developments Table 48. GSBPL Company Information Table 49. GSBPL Business Overview Table 50. GSBPL BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 51. GSBPL BCG Vaccine Product Portfolio Table 52. GSBPL Recent Developments Table 53. Global BCG Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 54. Global BCG Vaccine Sales by Region (2021-2026) & (MT) Table 55. Global BCG Vaccine Sales Market Share by Region (2021-2026) Table 56. Global BCG Vaccine Sales by Region (2027-2032) & (MT) Table 57. Global BCG Vaccine Sales Market Share by Region (2027-2032) Table 58. Global BCG Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global BCG Vaccine Revenue Market Share by Region (2021-2026) Table 60. Global BCG Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global BCG Vaccine Revenue Market Share by Region (2027-2032) Table 62. North America BCG Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. North America BCG Vaccine Sales by Country (2021-2026) & (MT) Table 64. North America BCG Vaccine Sales by Country (2027-2032) & (MT) Table 65. North America BCG Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 66. North America BCG Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 67. Europe BCG Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Europe BCG Vaccine Sales by Country (2021-2026) & (MT) Table 69. Europe BCG Vaccine Sales by Country (2027-2032) & (MT) Table 70. Europe BCG Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 71. Europe BCG Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 72. Asia Pacific BCG Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Asia Pacific BCG Vaccine Sales by Country (2021-2026) & (MT) Table 74. Asia Pacific BCG Vaccine Sales by Country (2027-2032) & (MT) Table 75. Asia Pacific BCG Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 76. Asia Pacific BCG Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 77. South America BCG Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. South America BCG Vaccine Sales by Country (2021-2026) & (MT) Table 79. South America BCG Vaccine Sales by Country (2027-2032) & (MT) Table 80. South America BCG Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 81. South America BCG Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 82. Middle East and Africa BCG Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Middle East and Africa BCG Vaccine Sales by Country (2021-2026) & (MT) Table 84. Middle East and Africa BCG Vaccine Sales by Country (2027-2032) & (MT) Table 85. Middle East and Africa BCG Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. Middle East and Africa BCG Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. Global BCG Vaccine Sales by Type (2021-2026) & (MT) Table 88. Global BCG Vaccine Sales by Type (2027-2032) & (MT) Table 89. Global BCG Vaccine Sales Market Share by Type (2021-2026) Table 90. Global BCG Vaccine Sales Market Share by Type (2027-2032) Table 91. Global BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 92. Global BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 93. Global BCG Vaccine Revenue Market Share by Type (2021-2026) Table 94. Global BCG Vaccine Revenue Market Share by Type (2027-2032) Table 95. Global BCG Vaccine Price by Type (2021-2026) & (USD/Kg) Table 96. Global BCG Vaccine Price by Type (2027-2032) & (USD/Kg) Table 97. Global BCG Vaccine Sales by Application (2021-2026) & (MT) Table 98. Global BCG Vaccine Sales by Application (2027-2032) & (MT) Table 99. Global BCG Vaccine Sales Market Share by Application (2021-2026) Table 100. Global BCG Vaccine Sales Market Share by Application (2027-2032) Table 101. Global BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 102. Global BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 103. Global BCG Vaccine Revenue Market Share by Application (2021-2026) Table 104. Global BCG Vaccine Revenue Market Share by Application (2027-2032) Table 105. Global BCG Vaccine Price by Application (2021-2026) & (USD/Kg) Table 106. Global BCG Vaccine Price by Application (2027-2032) & (USD/Kg) Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. BCG Vaccine Distributors List Table 110. BCG Vaccine Customers List Table 111. BCG Vaccine Industry Trends Table 112. BCG Vaccine Industry Drivers Table 113. BCG Vaccine Industry Restraints Table 114. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. BCG Vaccine Product Image Figure 5. Global BCG Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global BCG Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global BCG Vaccine Sales (2021-2032) & (MT) Figure 8. Global BCG Vaccine Average Price (USD/Kg) & (2021-2032) Figure 9. Immune BCG Product Image Figure 10. Therapy BCG Product Image Figure 11. Hospitals Product Image Figure 12. Clinics Product Image Figure 13. Others Product Image Figure 14. Global BCG Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 BCG Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global BCG Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global BCG Vaccine Sales by Region in 2025 Figure 20. Global BCG Vaccine Revenue by Region in 2025 Figure 21. North America BCG Vaccine Market Size by Country in 2025 Figure 22. North America BCG Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America BCG Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe BCG Vaccine Market Size by Country in 2025 Figure 28. Europe BCG Vaccine Sales Market Share by Country (2021-2032) Figure 29. Europe BCG Vaccine Revenue Market Share by Country (2021-2032) Figure 30. Germany BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific BCG Vaccine Market Size by Country in 2025 Figure 41. Asia Pacific BCG Vaccine Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific BCG Vaccine Revenue Market Share by Country (2021-2032) Figure 43. China BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America BCG Vaccine Market Size by Country in 2025 Figure 52. South America BCG Vaccine Sales Market Share by Country (2021-2032) Figure 53. South America BCG Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Brazil BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa BCG Vaccine Market Size by Country in 2025 Figure 58. Middle East and Africa BCG Vaccine Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa BCG Vaccine Revenue Market Share by Country (2021-2032) Figure 60. Egypt BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries BCG Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global BCG Vaccine Sales Market Share by Type (2021-2032) Figure 66. Global BCG Vaccine Revenue Market Share by Type (2021-2032) Figure 67. Global BCG Vaccine Price (USD/Kg) by Type (2021-2032) Figure 68. Global BCG Vaccine Sales Market Share by Application (2021-2032) Figure 69. Global BCG Vaccine Revenue Market Share by Application (2021-2032) Figure 70. Global BCG Vaccine Price (USD/Kg) by Application (2021-2032) Figure 71. BCG Vaccine Value Chain Figure 72. BCG Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. BCG Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Merck
  • Sanofi Pasteur
  • Japan BCG Lab
  • China National Biotec
  • Serum Institute of India
  • Intervax
  • GSBPL

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global BCG Vaccine Market Size (2021-2032)
  4. 2.2.2 Global BCG Vaccine Sales (2021-2032)
  5. 2.2.3 Global BCG Vaccine Market Average Price (2021-2032)
  6. 2.3 BCG Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Immune BCG
  9. 2.3.3 Therapy BCG
  10. 2.4 BCG Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Clinics
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global BCG Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global BCG Vaccine Sales (MT) of Manufacturers (2021-2026)
  3. 3.3 Global BCG Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global BCG Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global BCG Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of BCG Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of BCG Vaccine, Established Date
  9. 3.9 Global BCG Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck BCG Vaccine Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 Sanofi Pasteur
  8. 4.2.1 Sanofi Pasteur Company Information
  9. 4.2.2 Sanofi Pasteur Business Overview
  10. 4.2.3 Sanofi Pasteur BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
  12. 4.2.5 Sanofi Pasteur Recent Developments
  13. 4.3 Japan BCG Lab
  14. 4.3.1 Japan BCG Lab Company Information
  15. 4.3.2 Japan BCG Lab Business Overview
  16. 4.3.3 Japan BCG Lab BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
  18. 4.3.5 Japan BCG Lab Recent Developments
  19. 4.4 China National Biotec
  20. 4.4.1 China National Biotec Company Information
  21. 4.4.2 China National Biotec Business Overview
  22. 4.4.3 China National Biotec BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 China National Biotec BCG Vaccine Product Portfolio
  24. 4.4.5 China National Biotec Recent Developments
  25. 4.5 Serum Institute of India
  26. 4.5.1 Serum Institute of India Company Information
  27. 4.5.2 Serum Institute of India Business Overview
  28. 4.5.3 Serum Institute of India BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Serum Institute of India BCG Vaccine Product Portfolio
  30. 4.5.5 Serum Institute of India Recent Developments
  31. 4.6 Intervax
  32. 4.6.1 Intervax Company Information
  33. 4.6.2 Intervax Business Overview
  34. 4.6.3 Intervax BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Intervax BCG Vaccine Product Portfolio
  36. 4.6.5 Intervax Recent Developments
  37. 4.7 GSBPL
  38. 4.7.1 GSBPL Company Information
  39. 4.7.2 GSBPL Business Overview
  40. 4.7.3 GSBPL BCG Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GSBPL BCG Vaccine Product Portfolio
  42. 4.7.5 GSBPL Recent Developments
5 Global BCG Vaccine Market Scenario by Region
  1. 5.1 Global BCG Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global BCG Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global BCG Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global BCG Vaccine Sales by Region: 2027-2032
  5. 5.3 Global BCG Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global BCG Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global BCG Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America BCG Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America BCG Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America BCG Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America BCG Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe BCG Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe BCG Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe BCG Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe BCG Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific BCG Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific BCG Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific BCG Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific BCG Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America BCG Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America BCG Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America BCG Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America BCG Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa BCG Vaccine Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa BCG Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa BCG Vaccine Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa BCG Vaccine Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global BCG Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global BCG Vaccine Sales by Type (2021-2032) & (MT)
  3. 6.1.2 Global BCG Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global BCG Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global BCG Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global BCG Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global BCG Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global BCG Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global BCG Vaccine Sales by Application (2021-2032) & (MT)
  3. 7.1.2 Global BCG Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global BCG Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global BCG Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global BCG Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global BCG Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 BCG Vaccine Value Chain Analysis
  2. 8.1.1 BCG Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 BCG Vaccine Production Mode & Process
  5. 8.2 BCG Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 BCG Vaccine Distributors
  8. 8.2.3 BCG Vaccine Customers
9 Global BCG Vaccine Analyzing Market Dynamics
  1. 9.1 BCG Vaccine Industry Trends
  2. 9.2 BCG Vaccine Industry Drivers
  3. 9.3 BCG Vaccine Industry Opportunities and Challenges
  4. 9.4 BCG Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst